PA8.DEライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (2 11月 2023 @ 01:36):

Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and critical care services worldwide...

Stats
本日の出来高	5 275.00
平均出来高	18 739.00
時価総額	2.71M
EPS	€0 ( 2024-04-21 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-0.130
ATR14	€0.380 (105.56%)

ボリューム相関

長: -0.58 (weak negative)

短: 0.13 (neutral)

Signal:(15.842) Neutral

Paion AG 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Paion AG 相関 - 通貨/商品

-0.07
( neutral )

-0.78
( moderate negative )

-0.31
( neutral )

-0.34
( neutral )

0.71
( moderate )

0.02
( neutral )

Paion AG 財務諸表

Annual	2022
収益:	€33.25M
総利益:	€31.29M (94.10 %)
EPS:	€-0.0812

FY	2022
収益:	€33.25M
総利益:	€31.29M (94.10 %)
EPS:	€-0.0812

FY	2021
収益:	€7.13M
総利益:	€4.05M (56.83 %)
EPS:	€-0.310

FY	2020
収益:	€19.66M
総利益:	€19.66M (100.00 %)
EPS:	€0.0295

Financial Reports:

No articles found.

Paion AG

Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and critical care services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation. It is also developing Angiotensin II, a vasoconstrictor indicated for the treatment of refractory hypotension in adults with septic or other distributive shock; and Eravacycline, a novel fluorocycline antibiotic indicated for the treatment of complicated intra-abdominal infections in adults. The company has partnerships and license agreements with Cosmo Pharmaceuticals, Wuhan Humanwell Innovative Drug Research and Development Center Limited Company, Hana Pharm, Yichang Humanwell, and Mundipharma. Paion AG was founded in 2000 and is based in Aachen, Germany.